The proposed change to making skin cancer screening a general mandatory benefit has met with substantial criticism, but Health Minister Nina Warken (CDU) defended the measure, characterizing it as a necessary effort to improve focus. Warken admitted that she initially viewed the plans with skepticism, stating, “I questioned it myself” during an appearance on the ntv program “Pinar Atalay” on Monday. Nevertheless, she maintains that the revised regulation represents the correct path toward making the healthcare system more efficient.
Warken clarified that the screening is not being eliminated altogether, but rather made “more targeted”. Moving forward, it is expected that high-risk groups will primarily benefit from the examination. She noted, “No country performs skin cancer screening on everyone like we do”. She pointed out that even sun-intensive countries, such as Australia, do not offer comprehensive screening for all age and risk demographics.
Another reason cited for this realignment is the significant shortage of dermatological appointments. By allocating resources more strategically, the goal is to ensure that patients with an actual risk are seen faster. Warken expressed confidence in the new approach, saying, “It is convincing to say: We are looking closely at where a certain risk exists”. Patients are advised to seek consultation to clarify their individual needs.
However, professional associations criticize the reform, warning that restricting preventative checks could ultimately lead to an increase in illnesses and higher costs. Warken countered this expert view, explaining that the Federal Joint Committee (GBA) will now determine the precise guidelines regarding who will qualify for the complimentary screening. The objective is to fund only those measures that demonstrate a “provable benefit”.